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Mitochondria are key regulators of intracellular Ca2+ homeostasis. The tight control of 
mitochondrial Ca2+ entry and cycling is therefore critical to avoid alterations underlying 
the development of severe pathological conditions, including cancer and 
neruodegeneration. The mitochondrial Ca2+ uniporter (MCU) complex is 
acknowledged as the mediator of Ca2+ influx into mitochondria. Nevertheless, the 
mechanisms governing its expression and activity remain ill-defined. Here, we show 
that the mitochondrial protein ATPase inhibitory factor 1 (IF1) regulates MCU-
dependent Ca2+ uptake via a retrograde-signal-mediated regulatory mechanism. IF1 is 
a key mediator of mitochondrial energy preservation, and its loss correlates with higher 
mitochondrial membrane potential (ΔΨm), increased generation of  reactive oxygen 
species (ROS), alterations in the inner mitochondrial structure and engagement of 
mitochondrial apoptosis under stress. Here we show that, in IF1-depleted HeLa cells, 
mitochondria sequester Ca2+ more efficiently following intracellular mobilization. This 
event is paired with decreased cellular ATP levels, inducing the activation of the 
AMPK/CREB pathway and the consequent upregulation of the MCU complex. 
Interestingly, down-regulation of the mitochondrial inner membrane metalloprotease 
OMA1, which promotes OPA1 processing and cristae remodelling in response to 
stress, prevents cellular ATP depletion and restores physiological levels of MCU and 
mitochondrial Ca2+ entry. We propose that impaired mitochondrial bioenergetic 
function induced by loss of IF1 underlies mitochondrial dysfunction exacerbated 
through excessive Ca2+ uptake via MCU. 













Calcium ions (Ca2+) are universal intracellular messengers that control a diverse array 
of cellular functions, including cell metabolism (1), migration (2), division (3) and death 
(4). Other physiological roles of Ca2+ comprise the regulation of muscle contraction, 
nerve contractility, hormone secretion (5) and immune response (6). The versatility of 
Ca2+ signalling depends on Ca2+ interaction with a wide range of intracellular sensors 
and transducers through varied spatiotemporal dynamics. This implies that cells has 
to maintain their cytosolic  free Ca2+ concentration at very low levels (~100 nM) to 
allow for the sudden, rapid and compartmentalized Ca2+ transients. Intracellular Ca2+ 
signalling is therefore allowed by the presence of plasma membrane Ca2+ pumps and 
intracellular Ca2+ stores. The former constantly transport the dication out of the cell to 
maintain its 20000-fold gradient across the plasmalemma (7), while the latter rapidly 
uptake or release Ca2+ to quench or initiate Ca2+ signals. The presence of intracellular 
stores also enable the functional organization of Ca2+ transients in signalling 
microdomains. Together with the endoplasmic reticulum, which is the main 
intracellular site of Ca2+ storage, mitochondria have a central role as dynamic Ca2+ 
buffers. Mitochondrial Ca2+ handling is a fundamental feature of mitochondrial 
physiology. By sequestering and releasing Ca2+, mitochondria act as hubs for Ca2+ 
storage and buffering, thereby tuning the local Ca2+ availability and shaping cellular 
Ca2+ signals (8-10). The movements of Ca2+ across mitochondria mainly depend on 
the activity of the mitochondrial Ca2+ uniporter (MCU), which regulates the influx 
pathway, and the Na+/Ca2+(NCLX) and H+/Ca2+ (mHCX) exchangers, which instead 
control Ca2+ efflux. Even though the molecular determinants of these cation channels 
have been extensively characterized (11,12), the mechanisms regulating their function 
have not been yet fully unravelled. Moreover, in recent years, a vast body of evidence 
has emerged linking defective mitochondrial Ca2+ handling to an ever expanding 
number of pathological conditions, including neurodegenerative diseases (13-17). 
Hence, furthering the current understanding of the mechanisms that regulate 
mitochondrial Ca2+ homeostasis is crucial to the development of advanced, targeted 
treatment options. 
Mitochondrial Ca2+-storage capacity is highly correlated with the bioenergetic state of 
mitochondria. Mitochondrial Ca2+-uptake is driven by both high mitochondrial 
membrane potential (ΔΨm) and low intramatrix concentration of the dication (18). 
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The extent of the latter is indirectly regulated by the rate of respiration and oxidative 
phosphorylation. By establishing the proton-motive force across the mitochondrial 
inner membrane, they directly control the electrical gradient favouring Ca2+ entry, and 
indirectly set the chemical gradient through the activity of NCLX and mHCX. On the 
other hand, Ca2+ is a major regulator of ATP production. Changes in mitochondrial 
matrix Ca2+ concentration modulate the activity of various mitochondrial 
dehydrogenases and the F1Fo-ATP synthase, thereby promoting the TCA cycle and 
ATP synthesis (19,20). 
Ca2+ is therefore a key regulator of the activity state of the F1Fo-ATP synthase, in 
combination with the mitochondrial protein ATPase inhibitory factor 1 (IF1) (21). The 
latter primarely acts as a modulator of the F1Fo-ATP synthase, inhibiting ATP 
hydrolysis during conditions of impaired ΔΨm, when the enzymatic complex acts in 
reverse. Hence, IF1 prevents excessive ATP hydrolysis, cell energy imbalance and 
death under ischaemia/hypoxia (22,23). Recent studies, including works from our 
group, have revealed the existence of a larger plethora of functions for IF1, and 
outlined the pathological implications of its deregulation (24-28). 
In particular, we recently uncovered a role for the ATPase inhibitory factor 1 (IF1) in 
evasion of apoptosis, which contributes to the pro-tumorigenic function of the protein 
(29,30). This oncogenic mechanism occurs through OPA1-dependent maintenance of 
cristae shape and preservation of redox balance. Loss of IF1 activity in HeLa cells 
promotes stress-dependent OPA1 degradation, causing the presence of mitochondria 
with abnormal cristae morphology, which ultimately impairs cell metabolism 
predisposing to cell death. To further investigate into the impact of IF1 on mitochondrial 
function, we here studied the role of the inhibitory protein in down-regulating 
mitochondrial Ca2+ buffering capacity. Our interest stemmed from the notion that 
alterations in mitochondrial Ca2+ handling can lead to pathological cell death through 
mitochondrial swelling and permeability transition (18), which are both counteracted 
when IF1 is over-expressed (30). Moreover, mitochondrial Ca2+ buffering capacity 
appears to be impaired in cells devoid of OPA1 (31,32), which accumulate Ca2+ at a 
greater extent. 
The present study uncovers a novel function for IF1 in the control of mitochondrial Ca2+ 
homeostasis, and describes the existence of an AMPK-mediated adaptive mechanism 
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through which inefficient respiration and ATP synthesis, in the absence of IF1, drive 
MCU upregulation to preserve mitochondrial function. The pathway is promoted by the 
activation of OMA1, a metalloendopeptidase involved in mitochondrial inner 
membrane remodelling. This further proves the tight correlation between mitochondrial 




Materials and Methods 
Cell lines, culture and transfection 
HeLa cervical adenocarcinoma cells stably transduced with an shRNA targeting 
human IF1 mRNA (IF1 KD) or a non-silencing shRNA (Scrm) were cultured according 
to standard tissue culture protocols as described in Supporting Information. 
TEM 
Control and IF1 KD HeLa were fixed and processed for transmission electron 
microscopy as previously described (33). Images were acquired using a JEOL JEM-
1010 transmission electron microscope and analysed as reported in Supporting 
Information. 
Live-cell imaging 
Live-cell imaging of cytosolic free Ca2+ transients was carried using the fluorescent 
Ca2+ indicator Fura-2, AM. Mitochondrial Ca2+ uptake was evaluated by using the 
genetically encoded, mitochondria-targeted ratiometric fluorescent probe 
2mtGCaMP6m (34). A detailed description of the imaging and analysis methods is 
reported in Supporting Information. 
Western blotting 
Cells were harvested 24 hours after cell seeding or 48 hours after transfection and 
processed as described in Supporting Information. In all experiments, protein samples 
were separated on a polyacrylamide gel and then transferred onto a PVDF membrane. 
After incubation with the appropriate primary and HRP-conjugated secondary 
antibodies, protein bands were detected using chemiluminescence and quantified via 
densitometry. For a list of antibodies and incubation conditions please refer to 
Supporting Information. 
Quantification of total cellular ATP content 
Relative intracellular ATP levels were determined 24 hours after cell seeding or 48 
hours from transfection using a chemiluminescent detection assay as reported in 
Supporting Information. 
Real-time quantitative PCR 
Total cellular RNA was extracted 24 hours after cell seeding and 1 µg RNA was 
retrotranscribed for each sample as described in Supporting Information. Real-time 
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quantitative PCR was performed loading 1:20 cDNA sample per reaction and analysed 





IF1 loss increases intracristal space and Ca2+ accumulation 
We previously reported that stable knock-down of IF1 in HeLa cells causes abnormal 
topology of the mitochondrial inner membrane, which is characterized by a reduced 
folding and the appearance of distorted, horseshoe-shaped cristae (33). Interestingly, 
mitochondrial cristae in IF1 KD cells also have a significant increase in width, which is 
particularly noticeable at the crista junctions (Figure 1A,B). While this observation 
goes in line with the reduced stability of OPA1 observed in cells lacking IF1 function 
(33), it might also underlie alteration in molecular diffusion from the intermembrane 
space into the mitochondrial matrix (35). To test the hypothesis that knocking-down 
IF1 alters mitochondrial Ca2+ handling and favours the accumulation of Ca2+ into the 
mitochondrial matrix, control and stable IF1 KD HeLa cells were co-transfected with 
mitochondria-targeted GCaMP6m (2mtGCaMP6m)  and red fluorescent protein 
(mtRFP), to follow mitochondrial Ca2+ uptake over time after the administration of the 
calcium mobilising agonist histamine. Immediately after histamine administration, 
transfected cells responded with a transient increase in 2mtGCaMP6m fluorescence, 
which corresponded to a mitochondrial Ca2+ spark (Figure 1C). Despite the absence 
of variations in the basal intramitochondrial Ca2+ levels (Figure 1E), the amplitude of 
the mitochondrial fluorescence increase was around 50% higher in IF1 KD cells 
(Figure 1D), indicating a higher mitochondrial Ca2+ uptake capacity. Nevertheless, we 
did not observe any difference between the two cell types in both amplitude and 
dynamics of histamine-induced intracellular Ca2+ rise, which was monitored by staining 
cells with Fura-2 AM (Figure 1F,G). Histamine induces intracellular Ca2+ mobilization 
by activating H1 histamine receptors and causing both emptying of intracellular ER 
stores via phospholipase C and capacitative Ca2+ influx from the extracellular 
environment (36,37). This two-phase increase response might explain why the 
augmented mitochondrial Ca2+ uptake capacity of IF1 KD cells was not matched by 
changes in cytosolic buffering. Therefore, to measure the Ca2+ uptake capacity of 
mitochondria following ER emptying alone, and highlight variations in the coupling 
between the two organelles, we then used the sarco/endoplasmic reticulum Ca2+-
ATPase (SERCA) inhibitor thapsigargin to promote the passive release of Ca2+ from 
the ER. Confirming the previous results, IF1 KD cells exhibited a 50% increase in 
mitochondrial accumulation of Ca2+, the levels of which also stayed elevated for longer 
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due to inhibition of ER Ca2+ reuptake (Figure 1H,I). Moreover, IF1 loss also disturbed 
the whole-cell Ca2+ homeostasis, as confirmed by the lower levels of cytosolic Ca2+ 
accumulation (Figure 1J,K). 
IF1 loss induces MCU upregulation through AMPK-dependent CREB activation 
We then questioned what might cause the increase in mitochondrial Ca2+ uptake in 
cells down-regulated for IF1. In our cell model, the reduction in IF1 activity has been 
correlated with higher mitochondrial membrane potential and impaired ATP synthesis 
at resting conditions (38-40). Therefore, these conditions might enhance mitochondrial 
Ca2+ entry in IF1 KD cells as an adaptive mechanism to maximize ATP production by 
enhancing oxidative phosphorylation (41-43). Alternatively, the increase in 
mitochondrial Ca2+ uptake might be sustained by increased activity of the 
mitochondrial calcium uniporter (MCU) complex. Hence, we analysed via Western 
blotting the protein levels of the pore forming subunit of the complex, MCU itself. Quite 
unexpectedly, MCU expression was greatly increased in IF1 KD cells (Figure 2A,B) 
independently of mitochondrial mass, as quantified via immunodetection of ATPB and 
VDAC (Figure 2D,E). To further investigate the mechanism of MCU-dependent 
increase in mitochondrial Ca2+ entry in IF1 KD cells, we looked at changes in mRNA 
and protein levels of the different components of the MCU complex. In accordance 
with the Western blotting data, IF1 KD cells showed a nearly 1.6 increase in MCU 
transcript levels, which was matched by an approximately 1.5-fold increase in the 
expression of all other subunits with the exception of a 2-fold increase in that of EMRE 
(Figure 2F). By measuring the expression ratio of the MCU complex subunits to MCU 
itself, it also appears that in IF1 KD cells the stoichiometry of the complex is maintained 
(Figure 2G). This might indicate that IF1 KD cells have a higher mitochondrial content 
of fully functional, non-constitutively active, MCU complex. To investigate further into 
the mechanism leading to MCU upregulation in IF1 KD cells, we then checked the 
expression and activation status of cAMP response element-binding protein (CREB), 
a known transcriptional regulator of MCU transcription (44,45). Among the CREB 
activating pathways, we focused on 5' AMP-activated protein kinase (AMPK)-
mediated signalling (46,47). First, increased levels of AMPK activation has recently 
been shown in the heart of IF1 KO mice (48). 
Secondly, our data indicated that knock-down of IF1 attenuates intracellular Ca2+ 
signalling, therefore ruling out the initiation of CREB-dependent MCU transcription 
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following a rise in cytosolic free Ca2+ levels (44,49). To confirm the involvement of an 
AMPK-mediated, CREB-dependent mechanism of MCU expression, we quantified the 
total and phosphorylated protein levels for both factors (Figure 2H-O). Our results 
showed a remarkable increase in the  degree of both AMPKα and CREB 
phosphorylation when IF1 is down-regulated (2- and 1.5-fold increase, respectively; 
Figure 2J,N). Of notice, while the total levels of CREB were unchanged between the 
two cell lines, AMPKα expression was significantly higher in IF1 KD cells (Figure 2I,M). 
This indicates that IF1 depletion promotes AMPK activity via upregulation of the protein 
rather than by augmenting the rate of its phosphorylation, which is not affected by 
changes in IF1 expression (Figure 2K). Collectively, our data suggest that IF1 might 
control MCU expression in resting cells by limiting AMPK-mediated CREB activation, 
which is instead enhanced when the protein is down-regulated (Figure 2O). Further 
confirming this hypothesis, treatment with the adenylate cyclase activator forskolin, 
which triggers  CREB-mediated gene transcription, significantly increased MCU 
expression and protein levels in control cells (Figure 2Q-S). This result validate MCU 
as a CREB-dependent genes in our cell model. Considering that AMPK is rapidly 
activated when ATP production decreases, and that a reduction in intracellular ATP 
levels has been documented in IF1 knock-down HeLa cells (38), we compared the total 
cellular ATP levels between the two cell lines to confirm the loss of ATP-dependent 
increase in AMPK activity. As expected, IF1 KD cells showed a nearly 40% decrease 
in cellular ATP levels (Figure 2P). 
Down-regulation of OMA1 limits MCU upregulation and mitochondrial Ca2+ 
uptake in IF1 KD cells 
Even though the role of the MCU complex as master regulator of mitochondrial Ca2+ 
entry is aknowlegded, it has also been proposed that the geometry of crista junctions, 
which is altered when IF1 is down-regulated (Figure 1), might control mitochondrial 
Ca2+ fluxes (35). Moreover, Ca2+ uptake appears to be facilitated by unfolding of the 
cristae through alteration of the membrane diffusion barrier, such as during 
mitochondrial swelling (50). For this reason, we speculated that the lack of IF1 might 
also favour mitochondrial Ca2+ accumulation by promoting basal levels of OMA1-
dependent destabilization of OPA1 oligomers. The activation of the mitochondrial zinc 
metallopeptidase OMA1, and the subsequent proteolytic degradation of OPA1, rapidly 
occur under stress conditions and are prevented by IF1 (33). To test this hypothesis, 
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we measured intracellular Ca2+ mobilization following TPG administration in IF1 KD 
cells down-regulated for OMA1. Interestingly, this was sufficient to reduce 
mitochondrial Ca2+ uptake to levels comparable to control cells (Figure 3A,B), thus 
restoring the normal TPG-induced cytosolic Ca2+ response (Figure 3C,D). Moreover, 
knocking-down OMA1 inhibited the increase in MCU protein levels observed in IF1 KD 
cells (Figure 3E,F), while leaving the expression of ATPB and VDAC unchanged 
(Figure 3H,I). 
Although the m-AAA protease subunits SPG7 and AFG3L2 take part in the 
degradation of non-assembled EMRE, ensuring gatekeeping of MCU (51,52), there is 
no evidence to date for a direct role of OMA1 in the proteolytic regulation of the MCU 
complex. Nevertheless, OMA1 KO mice have been recently shown to be protected 
against heart failure (53). In this animal model,  cristae integrity is protected (i), there 
is lower mtROS-mediated oxidative damage (ii) and reduced energetic collapse 
following isoproterenol administration (iii). Furthermore it also prevents isoproterenol-
induced MCU upregulation and mitochondrial Ca2+ overload (53). To test whether 
silencing of OMA1 in IF1 KD cells might prevent MCU upregulation by restoring 
mitochondrial function and promoting ATP synthesis, we repeated measurements of 
intracellular ATP levels after silencing of OMA1 (Figure 3J). Down-regulation of the 
peptidase significantly reduced the loss of ATP production in cells depleted of IF1, 
further confirming that the activation of OMA1 critically promotes mitochondrial 





With this work, we demonstrated that IF1 is required for maintaining mitochondrial Ca2+ 
homeostasis. Our data prove that IF1 down-regulation triggers an AMPK-mediated 
mitochondrial retrograde signalling response that results in the CREB-dependent 
over-expression of MCU, and leads to the increased propensity of mitochondria to 
accumulate Ca2+ in response to stimuli emptying the ER stores (as illustrated in Figure 
4). While this may represent an adaptive mechanism to overcome the mitochondrial 
bioenergetic imbalance and oxidative stress caused by the loss of IF1 (33,38,54), it 
might also contribute to the structural derangement that characterizes IF1 KD cells 
(Figure 1) (33). Indeed, the activation of the AMPK signalling pathway following IF1 
depletion (Figure 2) (48) might be exploited by cells to promote their growth and 
metabolic reprogramming (55), thereby compensating for the drop in ATP that 
characterizes IF1 KD cells (Figure 2) (38) through CREB-induced MCU upregulation. 
A higher intramitochondrial Ca2+ availability in IF1 KD cells can counteract the decline 
in oxidative phosphorylation, but contemporaneously set the conditions for structural 
derangements. In accordance with this hypothesis, IF1 KD cells show alteration in their 
mitochondrial structure (Figure 1) despite no changes in their function (Supp. Figure 
1A).  Interestingly, MCU activity and increased intramitochondrial Ca2+ levels are 
required for the constriction of the inner mitochondrial membrane (IMM) during 
mitochondrial fission (56). Moreover, in conditions of impaired oxidative metabolism, 
AMPK activation also promotes mitochondrial fragmentation via mitochondrial fission 
factor (Mff)-mediated Drp1 recruitment (57). Therefore, the higher mitochondrial Ca2+ 
uptake capacity of IF1 KD cells, along with the AMPK activity, might inscrease 
susceptibility of these cells to undergo mitochondrial fragmentation (30).  
We also found that silencing of the mitochondrial protease OMA1 restores normal 
MCU levels and mitochondrial Ca2+ uptake (Figure 3). This indicates that OMA1 is 
involved in the pathway activated by IF1 loss. As we previously described, the over-
expression of IF1 prevents the stress-triggered activation of OMA1, thereby limiting the 
processing of its target OPA1 and counteracting mitochondrial cristae remodelling 
(33). Here we prove that reduced IF1 levels correlate with increased MCU expression 
and mitochondrial Ca2+ buffering capacity only in the presence of OMA1, suggesting 
that IF1 controls OMA1 activity even under resting conditions. We can therefore 
hypothesize that the alteration in the mitochondrial ultrastructure observed in IF1-
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depleted cells is caused by a combinatory effect of high Ca2+ and OMA1 stabilization 
through ATP depletion. Moreover, our data suggest that the mitochondrial 
ultrastructure regulates mitochondrial Ca2+ buffering capacity. Indeed, the higher 
resting-state levels of OMA1-mediated OPA1 degradation of IF1 KD cells (33) reinforce 
the mitochondrial accumulation of Ca2+ dependent on MCU upregulation. Restoring 
OPA1 function through OMA1 inhibition in IF1 KD cells would favour folding of the 
cristae and respiratory chain supercomplex assembly, improving both mitochondrial 
bioenergetics and function. This in turn reduces AMPK activation by restoring 
suboptimal ATP levels (Figure 3). Up to date, the studies on IF1 have mainly been 
focused on dissecting its function in pathological scenario, such as hypoxia/ischaemia 
and cancer. 
Collectively, our data prove that loss of the inhibitory protein impairs mitochondrial 
Ca2+ import. This might entail important consequences in both cell physiology and 
pathology, as it might facilitate mitochondrial Ca2+ overload, contributing to the 
derangement of mitochondrial cristae structure and swelling of the organelle. IF1 KD 
cells are characterized by a substantial increase in the average cristae width, an event 
that, in combination with the augment in active MCU complexes, might favour Ca2+ 
entry. Nevertheless, definitive evidence confirming that cristae enlargement has a 
direct effect on mitochondrial Ca2+ dynamics is still missing. Alongside, the relationship 
between mitochondrial Ca2+ handling and structure is yet poorly understood. Our work 
proposes that IF1 is a key player in this pathway, as well as a molecular mediator of 
the retrograde response that links impaired mitochondrial bioenergetics and structure 
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Legends to Figures 
 
Figure 1: IF1 knock-down induces mitochondrial intracristal space enlargement 
and enhances mitochondrial Ca2+ uptake in HeLa cells. 
(A) Representative electron micrographs of mitochondrial ultrastructure in Scrm and 
IF1 KD cells (scale bar: 500 nm). 
(B) Quantification of average cristae width in the two cell lines. 
(C) Prototypical traces of changes in [Ca2+]m, visualized with 2mtGCaMP6m, upon 
administration of 100 µM His in Scrm and IF1 KD cells. 
(D-E) Bar charts of average peak (D) and basal (E) [Ca2+]m in the two cell lines. 
(F) Representative Fura-2, AM traces describing [Ca2+]i dynamics in Scrm and IF1 KD 
cells following administration of 100 µM His. (G) Bar chart of average peak [Ca2+]i. 
(H) Exemplary traces of TPG-induced mitochondrial Ca2+ uptake in Scrm and IF1 KD 
cells transfected with 2mtGCaMP6m and challenged with 100 nM TPG. 
(I) Average 2mtGCaMP6m fluorescence ratio at plateau in the two cell lines. 
(J) Prototypical example of TPG-evoked [Ca2+]i rise in Scrm and IF1 KD cells loaded 
with Fura-2, AM and exposed to 100 nM TPG. 
(K) Quantification of average Fura-2, AM plateau fluorescence ratio in the two cell 
lines. 
 
Figure 2: MCU is upregulated in IF1 KD cells via increased AMPK/CREB 
signalling. 
(A) Representative Western blot of three independent experiments to measure the 
protein levels of MCU in Scrm and IF1 KD cells. Lysates were also tested for VDAC1, 
ATPB and IF1. GAPDH was used as loading control. 
(B-E) Bar charts reporting quantitative analysis of the protein levels of MCU (B), IF1 
(C), VDAC1 (D) and ATPB (E) relative to GAPDH. 
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(F) Gene expression analysis of MCU complex subunits in IF1 KD and Scrm cells (blue 
line). β-actin (ACTB) was used as internal control. (G) Averaged ratios between the 
mRNA levels of MCU and the other subunits of the complex. 
(H) Cellular protein levels of AMPKα and phospho-AMPKα (Thr172) in Scrm and IF1 
KD cells, detected via Western blotting. 
(I-K) Quantification of the protein levels of AMPKα (I), phospho-AMPKα (J) and their 
relative ratio (K). Vinculin was used as loading control. 
(L) Western blot analysis of CREB and phospho-CREB (Ser133) levels in Scrm and 
IF1 KD cells. 
(M-O) Densitometry analysis of CREB (M) and phospho-CREB (N) relative to Vinculin 
(loading control). The ratio of expression between phophorylated and total CREB was 
also calculated (O). 
(P) Measurement of intracellular ATP levels in Scrm and IF1 KD cells with an ATP-
based luminescence assay. 
(Q) Western blot analysis of MCU levels in Scrm and IF1 KD cells after 4 hours 
treatment with 10 µM forskolin. DMSO was used as vehicle. IF1 protein band is shown 
to confirm efficient knock-down. 
(R) Densitometry analysis of MCU protein levels relative to vinculin (loading control). 
(S) qPCR analysis of MCU mRNA levels in Scrm and IF1 KD cells after 4 hours 
treatment with 10 µM forskolin. 
  
Figure 3: OMA1 knockdown rescues MCU-mediated increase in mitochondrial 
Ca2+-uptake in IF1 KD HeLa cells by restoring intracellular ATP levels.  
(A) Prototypical traces of changes in [Ca2+]m in Scrm and IF1 KD cells co-transfected 
with 2mtGCaMP and either an siRNA against OMA1 (siOMA1) or a non-silencing 
siRNA (siNC), and treated with TPG (100 nM). 
(B) Quantification of average 2mtGCaMP6m fluorescence ratio at plateau after 
addition of TPG in the two cell lines. 
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(C) Representative traces of [Ca2+]i dynamics following TPG treatment in Scrm and 
IF1 KD cells. 
(D) Column diagram of average Fura-2, AM fluorescence ratio at plateau. 
(E) Representative Western blot of MCU in Scrm and IF1 KD cells transfected with 
either siNC or siOMA1; OMA1, VDAC1, ATPB and GAPDH (loading control) protein 
levels were also detected. 
(F-I) Quantification of MCU (F), OMA1 (G), VDAC1 (H) and ATPB (I) protein 
expression levels relative to GAPDH. 
(J) Measurements of total intracellular ATP levels in Scrm and IF1 KD cells transfected 
with either siNC or OMA1 siRNA via ATP-based luminescence. 
 
Figure 4: Proposed model for IF1-dependent control of mitochondrial Ca2+ 
uptake. 
In IF1-depleted HeLa cells (A), the decline in cellular ATP levels induces the AMPK-
mediated, CREB-dependent transcription of genes encoding the MCU complex, 
causing increased mitochondrial Ca2+ uptake following emptying of the ER stores. This 
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